Common Virus May Fight Deadly Brain Tumors
                   
emaxhealth.com     May 20, 2008            

By targeting a common virus, doctors may be able to extend the lives of patients diagnosed with the most prevalent and deadly type of brain tumor, according to a study led by researchers in Duke's Preston Robert Tisch Brain Tumor Center. A type of herpes virus called human cytomegalovirus (CMV)... [read full story]                

Add a comment to the article
Type the code shown

View all news articles about:

- Related Topics

View other selected articles:

U. to conduct shrimp-allergy study

deseretnews.com     2 hrs ago   1 related          

Published: Thursday, July 24, 2008 12:11 a.m. MDT University of Utah medical researchers are looking for 50 people who are allergic to shrimp for a study aimed at creating a vaccine. Funded by the National Institutes of Health,...                

comments

Emergent BioSolutions Awarded Two Grants from NIAID to Support Development of the Company's...

genengnews.com     3 hrs ago   17 related          

News source: Business Wire Emergent BioSolutions Inc. announced today that it has secured two grants totaling over $4.5 million from The National Institute of Allergy and Infectious Diseases (NIAID) to fund the continued...                

comments

                   

Tobacco Plants & Cancer Vaccine, Topamax & Birth Defects, Deep Brain Stimulation for Depression

insidermedicine.com     5 hrs ago   21 related          

From Chicago - According to research in the Proceedings of the National Academy of Science, tobacco plants, typically known as a cause of cancer, may also help to fight the disease. Researchers infected tobacco plants with a...                

comments

Naturopathic docs should be licensed

aspentimes.com     1 hr ago          

Dear Editor: I was frustrated that the July 18 letter on alternative medicine (“Protect alternative health access”) repeats incorrect information about efforts to license naturopathic doctors in Colorado. Currently, there are...                

comments